CN
75-15-0
Applied Filters:
Keyword:'75-15-0'
Showing 1-30 of 1179 results for "75-15-0" within Technical Documents
Product Information Sheet-11417991001
100% 0 – 10% 50 – 75%
Bln I (Avr II) 25 – 50% 100% 25 – 50%
Dpn I 100% 75 – 100% 75 – 100%
Mae III 0 – 10% 10 – 25% 0 – 10%
Nde I 25 – 50% 100%
Product Information Sheet-11417959001
100% 0 – 10% 50 – 75%
Bln I (Avr II) 25 – 50% 100% 25 – 50%
Dpn I 100% 75 – 100% 75 – 100%
Mae III 0 – 10% 10 – 25% 0 – 10%
Nde I 25 – 50% 100%
The Vmax Nomograph
0.0075
0.
10
0.
05
0
0.
02
5
0.
01
0
0.
00
50
0.
00
15
0.
00
07
5
0.
00
05
0.
00
03
5
0.
00
02
5
Product Information Sheet - 11417983001
100% 0 – 10% 50 – 75%
Bln I (Avr II) 25 – 50% 100% 25 – 50%
Dpn I 100% 75 – 100% 75 – 100%
Mae III 0 – 10% 10 – 25% 0 – 10%
Nde I 25 – 50% 100%
Product Information Sheet - 11082035001
100
100
75–100
50–75
75–100
75–100
0–10
50–75
100
25–50
75–100
25–50
75–100
75-100
10–25
100
0–10
0–10
0–10
10–25
75–100
10–25
100
100
0–10
0–10
50–75
10–25
100
50–75
0–10
0–10
100
100
Product Information Sheet - 11417967001
100
100
75–100
50–75
75–100
75–100
0–10
50–75
100
25–50
75–100
25–50
75–100
75-100
10–25
100
0–10
0–10
0–10
10–25
75–100
10–25
100
100
0–10
0–10
50–75
10–25
100
50–75
0–10
0–10
100
100
Product Information Sheet - 11417975001
100
100
75–100
50–75
75–100
75–100
0–10
50–75
100
25–50
75–100
25–50
75–100
75-100
10–25
100
0–10
0–10
0–10
10–25
75–100
10–25
100
100
0–10
0–10
50–75
10–25
100
50–75
0–10
0–10
100
100
A comparative study of hydrophobic and hydrophilic lubricants for optimal combination of galenical and dissolution properties
itraconazole.
Dissolution performace of itraconazole
1000 mL SGFsp pH 1.2; 75 rpm
Time [min]
5
1
2
3
4
0
0 15 30 45 60 75 90 105 120
Pure itraconazole Tablets with
NovAseptic Mixer: High Shear In-Line Mixer Users guide, Technical Description, Installation, Operating Instructions, Maintenance
rotation (A) speed and rotor (E) speed.
15(36)
D
oc
um
en
t M
L-
0
75
The Effective Use of Protein Kinase Inhibitors
35
2
(1
0
µM
)
PD
9
80
59
(P
-2
15
) (
50
µ
M
)
SB
-2
03
58
0
(S
8
30
7)
(1
0
µM
Enhancing the Solubility of Active Pharmaceutical Ingredients Using Hot Melt Extrusion and Polyvinyl Alcohol
formulation 30% drug load in 900 mL SGFsp;
paddle speed at 75 rpm, total runtime 120 minutes; n = 3.
0
Time [min]
30
20
10
0
15 30 45 60 75 90 105 120
The Effective Use of Protein Kinase Inhibitors
35
2
(1
0
µM
)
PD
9
80
59
(P
-2
15
) (
50
µ
M
)
SB
-2
03
58
0
(S
8
30
7)
(1
0
µM
Ascentis Express F5 (pentafluorophenylpropyl) HPLC Columns
300 53992-U
15 300 54271-U
5 500 53998-U
15 500 54273-U
C8
5 75 53983-U
15 75 54229-U
5 100 53987-U
15 100 54260-U
5 200 53991-U
15 200 54262-U
Brochure: BIOshell Fused-Core® HPLC and UHPLC Columns for Biomolecule separation
efficiency.
0 5 10 15 20
0 2 4 6 8 10 12
0 5 10 15 20
0 2 4 6 8 10 12
Different Phase Chemistries Allows for Alternative Selectivity for Peptides
EmbryoMax® PMEF, Strain DR4, Irradiated, passage 3
densities for human ES cell culture
Dish size Volume Growth Area Cell Density
75 cm2 flask 12 - 15 mL 75 cm2 9.3 x 105 – 1.3 x 106
25 cm2 flask
EmbryoMax® PMEF, Strain DR4, Irradiated, passage 3
densities for human ES cell culture
Dish size Volume Growth Area Cell Density
75 cm2 flask 12 - 15 mL 75 cm2 9.3 x 105 – 1.3 x 106
25 cm2 flask
EmbryoMax® PMEF, Strain DR4, Mytomycin C treated, passage 3
densities for human ES cell culture
Dish size Volume Growth Area Cell Density
75 cm2 flask 12 - 15 mL 75 cm2 9.3 x 105 – 1.3 x 106
25 cm2 flask
Product Information Sheet - P5380
11 ≈ 70%
• pH 11.5 ≈ 0%
Effect of temperature at constant pH (pH = 8.5),
for 10 minutes (activity remaining):19
• 30 °C ≈ 25%
• 40 °C
118386 - Test procedure MQuant Copper Test / Kupfer-Test / Test Cuivre / Test Cobre
7.
75
07
6.
00
03
-X
X
X
X
X
X mg/l
118386
Al
MQuant®
1.5 ml
15
-
4
0
°C
pH
3
-
1
0
B
141464 Parteck MXP
dispersion).
35
40
25
30
20
15
5
10
0
C
ha
ng
e
in
m
as
s
(%
)
-
dr
y
Target
Calcium carbonate as a replacement for titanium dioxide in coating
105
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
b* L*a*
a*
a
nd
b
*
L*
L = 100
white
yellow
+b
green
-a
red
+a
blue
-b
L = 0
black
Product Information Sheet - N0788
working stock (µL)
39 0 0
5 µM negative control
siRNA working
stock (µL)
0 19.5 0
N-TER Buffer (µL) 111 55.5 75
EmbryoMax® PMEF, Strain DR4, Mytomycin C treated, passage 3
densities for human ES cell culture
Dish size Volume Growth Area Cell Density
75 cm2 flask 12 - 15 mL 75 cm2 9.3 x 105 – 1.3 x 106
25 cm2 flask
1.14798 - Test procedure MQuant CyanideTest
7.
75
91
2.
00
03
-X
X
X
X
X
X mg/l
1.14798
CN-
MQuant®
6 ml
15
-
4
0
°C
pH
4
.5
-
8
.0
B
Viral filtration of plasma-derived human IgG
ce
ss
fl
ux
(L
/m
2 /
h)
0 10 20 30 40 50 60
0
50
100
150
200
250
Figure 3 Pressure effect on NFP performance.
0
1.1
0
Data Sheet - A5970
well
pNA std 200 µM
µl per well
Buffer
µl per well
0 0 100
1 5 95
2 10 90
5 25 75
10 50 50
15 75 25
20
Data Sheet - A5220
well
200 µM pNA std
µl per well
Buffer
µl per well
0 0 100
1 5 95
2 10 90
5 25 75
10 50 50
15
Pharmacopoeia Monograph Methods
Area
75 0 (means no addition to standard concentration 75 ppm)( pp )
75 LOQ (means addition of LOQ concentration + 75 ppm)
75 25 % (means addition of 25% level = 18.75 + 75 ppm)
Data Sheet - A5470
well
pNA std 200 µM
µl per well
Buffer
µl per well
0 0 100
1 5 95
2 10 90
5 25 75
10 50 50
15 75 25
20
Data Sheet - A6845
well
pNA std 200 µM
µl per well
Buffer
µl per well
0 0 100
1 5 95
2 10 90
5 25 75
10 50 50
15 75 25
20
Page 1 of 40